Search
for

    Sort by

    Research 30 of 362

    1. Exacerbation of alopecia areata during pegylated interferon alpha-2b and ribavirin therapy, possibly due to the collapse of hair follicle immune privilege European Journal of Dermatology · 2014 · 10 citations
    2. Reversible alopecia universalis secondary to PEG-interferon ??-2b and ribavirin combination therapy in a patient with chronic hepatitis C virus infection European Journal of Gastroenterology & Hepatology · 2007 · 41 citations
    3. Dystrophic-Anagen Effluvium Occurring During Pegylated Interferon-α-2a/Ribavirin Therapy Hepatitis Monthly · 2015 · 2 citations
    4. Predictive factors for adverse dermatological events during pegylated/interferon alpha and ribavirin treatment for hepatitis C Journal of Clinical Virology · 2014 · 11 citations
    5. Cutaneous necrosis after injection of polyethylene glycol–modified interferon alfa Journal of The American Academy of Dermatology · 2005 · 26 citations
    6. Bullous Lesions at Polyethylene Glycol Interferon-alpha-2a Inoculation Site in a Hepatitis C Virus-infected Subject Acta Dermato Venereologica · 2007 · 2 citations
    7. Alopecia universalis after discontinuation of pegylated interferon and ribavirin combination therapy for hepatitis C: a case report Annals of Hepatology · 2014 · 3 citations
    8. Irreversible alopecia universalis during treatment with pegylated interferon-ribavirin for chronic hepatitis C virus infection: Case report and published work review Hepatology Research · 2012 · 9 citations
    9. Pegylated-interferon-α<sub>2a</sub>in clinical practice: how to manage patients suffering from side effects Expert Opinion on Drug Safety · 2011 · 17 citations
    10. Zinc: A complementary factor in the treatment of chronic hepatitis C? (Review) Molecular Medicine Reports · 2010 · 21 citations
    11. The influence of interferon on healthy and diseased skin Cytokine · 2018 · 32 citations
    12. CUTANEOUS T-CELL LYMPHOMA Dermatologic Clinics · 2001 · 11 citations
    13. Reversible Alopecia Universalis During Treatment with PEG-Interferon and Ribavirin for Chronic Hepatitis C Journal of Chemotherapy · 2005 · 27 citations
    14. Lichen planus and other cutaneous manifestations in chronic hepatitis C: pre- and post-interferon-based treatment prevalence vary in a cohort of patients from low hepatitis C virus endemic area Journal of the European Academy of Dermatology and Venereology · 2008 · 34 citations
    15. Interferon in the treatment of cutaneous T-cell lymphoma Dermatologic Therapy · 2003 · 107 citations
    16. Hair Changes due to Drugs Elsevier eBooks · 2018
    17. Cutaneous drug reactions Elsevier eBooks · 2010 · 1 citations
    18. The efficacy and particular side effects of therapy peginterferon alpha-2a acute hepatitis C hemodialysed patients International Journal of Infectious Diseases · 2016
    19. A Review of Adverse Cutaneous Drug Reactions Resulting from the Use of Interferon and Ribavirin Canadian Journal of Gastroenterology · 2009 · 64 citations
    20. Design of Liposome Formulations for CRISPR/Cas9 Enzyme Immobilization: Evaluation of 5-Alpha-Reductase Enzyme Knockout for Androgenic Disorders ACS Omega · 2023
    21. Aldesleukin Elsevier eBooks · 2015
    22. Photo-Responsive Ascorbic Acid-Modified Ag<sub>2</sub>S–ZnS Heteronanostructure Dropping pH to Trigger Synergistic Antibacterial and Bohr Effects for Accelerating Infected Wound Healing ACS Applied Materials & Interfaces · 2024 · 7 citations
    23. Alleviation of Multidrug Resistance by Flavonoid and Non-Flavonoid Compounds in Breast, Lung, Colorectal and Prostate Cancer International Journal of Molecular Sciences · 2020 · 45 citations
    24. Cutaneous Reactions in Patients with Chronic Hepatitis C Treated with Peginterferon and Ribavirin Dermatology · 2014 · 15 citations
    25. Review article: dermatological complications of immunosuppressive and anti-TNF therapy in inflammatory bowel disease Alimentary Pharmacology & Therapeutics · 2013 · 60 citations
    26. Madarosis, milphosis, eyelash trichomegaly, and dermatochalasis Clinics in Dermatology · 2015 · 10 citations
    27. Functionally enhanced placenta-derived mesenchymal stem cells inhibit adipogenesis in orbital fibroblasts with Graves’ ophthalmopathy 2020
    28. Alopecias Springer eBooks · 2015
    29. Trichoscopic signs in systemic lupus erythematosus: a comparative study with 109 patients and 305 healthy controls Journal of the European Academy of Dermatology and Venereology · 2019 · 29 citations
    30. Autoimmunity and autoimmune co-morbidities in psoriasis Immunology · 2018 · 49 citations